首页> 外文期刊>Microbial Pathogenesis >Brucella abortus mutants lacking ATP-binding cassette transporter proteins are highly attenuated in virulence and confer protective immunity against virulent B. abortus challenge in BALB/c mice
【24h】

Brucella abortus mutants lacking ATP-binding cassette transporter proteins are highly attenuated in virulence and confer protective immunity against virulent B. abortus challenge in BALB/c mice

机译:缺乏ATP结合盒转运蛋白的布鲁氏菌流产突变体的毒力高度减弱,并赋予BALB / c小鼠针对强毒的流产布鲁氏菌攻击的保护性免疫力

获取原文
获取原文并翻译 | 示例
           

摘要

Brucella abortus RB51 is an attenuated vaccine strain that has been most frequently used for bovine brucellosis. Although it is known to provide good protection in cattle, it still has some drawbacks including resistance to rifampicin, residual virulence and pathogenicity in humans. Thus, there has been a continuous interest on new safe and effective bovine vaccine candidates. In the present study, we have constructed unmarked mutants by deleting singly cydD and cydC genes, which encode ATP-binding cassette transporter proteins, from the chromosome of the virulent Brucella abortus isolate from Korean cow (referred to as IVK15). Both IVK150 Delta cydD and Delta cydC mutants showed increased sensitivity to metal ions, hydrogen peroxide and acidic pH, which are mimic to intracellular environment during host infection. Additionally, the mutants exhibited a significant growth defect in RAW264.7 cells and greatly attenuated in mice. Vaccination of mice with either IVK150 Delta cydC or IVK15,6,cydD mutant could elicit an anti-Brucella specific immunoglobulin G (IgG) and IgG subclass responses as well as enhance the secretion of interferon-gamma, and provided better protection against challenge with B. abortus strain 2308 than with the commercial B. abortus strain RB51 vaccine. Collectively, these results suggest that both IVK15 Delta cydC and IVK15 Delta cydD mutants could be an attenuated vaccine candidate against B. abortus. (C) 2016 Elsevier Ltd. All rights reserved.
机译:流产布鲁氏菌RB51是一种减毒疫苗株,最常用于牛布鲁氏菌病。尽管已知它可以在牛中提供良好的保护,但它仍然具有一些缺点,包括对利福平的抗性,人体内的残留毒力和致病性。因此,人们一直对新的安全有效的牛疫苗候选者感兴趣。在本研究中,我们从韩国母牛的强毒布鲁氏菌分离株(称为IVK15)的染色体中删除了单个编码cydD和cydC基因的突变体,该突变体删除了编码ATP结合盒转运蛋白的cydD和cydC基因。 IVK150 Delta cydD和Delta cydC突变体均显示出对金属离子,过氧化氢和酸性pH的增加的敏感性,它们在宿主感染期间模仿细胞内环境。此外,突变体在RAW264.7细胞中表现出明显的生长缺陷,在小鼠中大大减弱。用IVK150 Delta cydC或IVK15,6,cydD突变体对小鼠进行疫苗接种可引发抗小球藻特异性免疫球蛋白G(IgG)和IgG亚类应答,并增强干扰素-γ的分泌,并提供更好的针对B挑战的保护流产菌株2308比市售流产芽孢杆菌RB51疫苗要好。总体而言,这些结果表明,IVK15 Delta cydC和IVK15 Delta cydD突变体都可能是针对流产双歧杆菌的减毒候选疫苗。 (C)2016 Elsevier Ltd.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号